Login / Signup

Aberrant expression of Sec61α in esophageal cancers.

Kai BachmannMaximillian BockhornOliver MannFlorian GebauerMarco BlessmannJakob Robert IzbickiKatharina Grupp
Published in: Journal of cancer research and clinical oncology (2019)
Thus, Sec61α measurement has not an additional prognostic benefit for the patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • binding protein